Table 2.
Response to treatments of group 1 about gender and age group
| Age group | Male | Female |
|---|---|---|
| 20-30 years | 25 (42.3%) | 19 (31.66%) |
| 30-40 | 5 (8.47%) | 5 (8.47%) |
| 40-60 | 3 (5%) | 3 (5%) |
| Cure cases | 27 (81.8%) | 23 (84.61%) |
| Failure cases | 6 (18.18%) | 4 (15.38%) |
Response to treatments of group 1 about gender and age group
| Age group | Male | Female |
|---|---|---|
| 20-30 years | 25 (42.3%) | 19 (31.66%) |
| 30-40 | 5 (8.47%) | 5 (8.47%) |
| 40-60 | 3 (5%) | 3 (5%) |
| Cure cases | 27 (81.8%) | 23 (84.61%) |
| Failure cases | 6 (18.18%) | 4 (15.38%) |